Browsing Tag
cannabinoid pharmaceuticals
2 posts
Is MediPharm Labs’ CFO the CEO it needs? Why Greg Hunter’s interim role could reshape the company
MediPharm Labs names Greg Hunter interim CEO. Find out what this leadership change means for execution, strategy, and investor sentiment.
Is a C$16m LIFE offering from ZYUS Life Sciences the catalyst investors are watching in cannabinoid pharma?
ZYUS Life Sciences launches a C$15–16 million LIFE offering to accelerate clinical execution and regulatory readiness. Find out what it means for investors.